Treatment with clozapine and olanzapine and cardiac changes in patients with schizophrenia: An MRI study

被引：0
|
作者：
Osimo, E. F. [1 ,2 ]
Brugger, S. [1 ,2 ]
Howes, O. [1 ,2 ]
机构：
[1] Imperial Coll London, Hammersmith Campus,Du Cane Rd, London W12 0NN, England
[2] Psychiat Imaging Grp, Cambridge, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
MORTALITY;
D O I：
10.1016/j.euroneuro.2019.01.096
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.4.06
引用
收藏
页码：S704 / S705
页数：2
相关论文
共 50 条
  • [21] Effect of clozapine and olanzapine on cortical excitability in schizophrenia
    Ben Amor, C.
    Galinowski, A.
    Gueguen, B.
    Bourdel, M. C.
    Waismann, R.
    Granger, B.
    Debray, Q.
    Olie, J. P.
    Krebs, M. O.
    EUROPEAN PSYCHIATRY, 2007, 22 : S103 - S103
  • [22] Clozapine, olanzapine, risperidone, and haloperidol in refractory schizophrenia
    Mohr, P
    Volavka, J
    Lieberman, JA
    Czobor, P
    McEvoy, J
    Lindenmayer, JP
    Citrome, L
    Sheitman, B
    EUROPEAN PSYCHIATRY, 2000, 15 : 284S - 284S
  • [23] Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder
    Spina, Edoardo
    D'Arrigo, Concetta
    Migliardi, Gaetana
    Santoro, Vincenza
    Muscatello, Maria Rosaria
    Mico, Umberto
    D'Amico, Giuseppina
    Perucca, Emilio
    THERAPEUTIC DRUG MONITORING, 2006, 28 (05) : 599 - 602
  • [24] Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol on treatment-resistant patients with schizophrenia and schizoaffective disorder
    Bilder, RM
    Goldman, RS
    Volavka, J
    Czobor, P
    Hoptman, M
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, J
    Kunz, M
    Chakos, M
    Lieberman, JA
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 194 - 194
  • [25] CLOZAPINE VS. OLANZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA: SYSTEMATIC REVIEW AND METANALYSIS
    Souza, Juliano Santos
    Kayo, Monica
    Tassell, I.
    Elkis, H.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 321 - 322
  • [26] OBSESSIVE-COMPULSIVE SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA COMPARING TREATMENT WITH CLOZAPINE, OLANZAPINE, RISPERIDONE AND NO ANTIPSYCHOTICS: A LONGITUDINAL STUDY OF 550 PATIENTS AFTER 3 YEARS OF TREATMENT
    Beduin, Albertine Scheltema
    Meijer, Carin
    de Haan, Lieuwe
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S277 - S278
  • [27] Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine
    Machielsen, Marise
    Beduin, Albertine Scheltema
    Dekker, Nienke
    Kahn, Rene S.
    Linszen, Don H.
    van Os, Jim
    Wiersma, Durk
    Bruggeman, Richard
    Cahn, Wiepke
    de Haan, Lieuwe
    Krabbendam, Lydia
    Myin-Germeys, Inez
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (01) : 189 - 195
  • [28] Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
    Mier, Daniela
    Schirmbeck, Frederike
    Stoessel, Gabriela
    Esslinger, Christine
    Rausch, Franziska
    Englisch, Susanne
    Eisenacher, Sarah
    de Haan, Lieuwe
    Meyer-Lindenberg, Andreas
    Kirsch, Peter
    Zink, Mathias
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2019, 269 (08) : 931 - 940
  • [29] Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
    Daniela Mier
    Frederike Schirmbeck
    Gabriela Stoessel
    Christine Esslinger
    Franziska Rausch
    Susanne Englisch
    Sarah Eisenacher
    Lieuwe de Haan
    Andreas Meyer-Lindenberg
    Peter Kirsch
    Mathias Zink
    European Archives of Psychiatry and Clinical Neuroscience, 2019, 269 : 931 - 940
  • [30] An observational study of patients with treatment-resistant schizophrenia switched to olanzapine
    Karagianis, J
    LeDrew, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S279 - S279
12345